A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with type 1 diabetes.

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

Semaglutide (Ozempic) improves blood sugar control and weight loss in people with type 1 diabetes and obesity using insulin pumps, new study shows.

Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

An early study hints at an intriguing possibility: The weight-loss drug Ozempic might allow people newly diagnosed with Type 1 diabetes to drop their daily insulin shots.

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Patients with type 1 diabetes could possibly cease daily insulin injections thanks to the “miracle” weight loss drug Ozempic originally developed to combat type 2 diabetes, Metro News reported ...

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...

People often ask whether Ozempic helps them lose weight. Clinical trials have shown reductions in body weight among adults ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.

Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. Jennifer Zieba. Wed, July 2, 2025 at 9:00 PM UTC. When you buy through links on our articles, Future and its syndication ...

An early study hints at an intriguing possibility: The weight-loss drug Ozempic might allow people newly diagnosed with Type 1 diabetes to drop their daily insulin shots.